Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
Elizabeth C. Mormino(Allen Institute for Brain Science), Reisa A. Sperling(Brigham and Women's Hospital), Rebecca A. Betensky(Harvard University), Trey Hedden(Harvard University), Dorene M. Rentz(Harvard University), Rebecca E. Amariglio(Harvard University), Keith A. Johnson(Jacobson Holman (United States)), Aaron P. Schultz(Harvard University)
Cited by 329
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k